Journal of Clinical Endocrinology & Metabolism, Vol 73, 1197-1201, Copyright © 1991 by Endocrine Society

ARTICLES

Identification and cloning of a granule autoantigen (carboxypeptidase- H) associated with type I diabetes

L Castano, E Russo, L Zhou, MA Lipes and GS Eisenbarth
Joslin Diabetes Center, Harvard Medical School, Brigham and Women's Hospital, New England Deaconess Hospital, Boston, Massachusetts 02215.

Using serum from a prediabetic patient as a probe, we screened 0.5 x 10(6) recombinants from a rat islet lambda gt11 expression library. One plaque-producing antigen reactive with this prediabetic serum was identified, subcloned, and sequenced. Analysis of the sequence reveals that the clone encodes a 136-amino acid fragment of carboxypeptidase-H (enkephalin convertase). Carboxypeptidase-H is a molecule expressed within islet secretory granules and neurendocrine cells. The patient whose antibodies recognize this recombinant molecule (termed DG-1) was negative for anti-DG-1 antibodies in 1984, developed the antibodies by 1986, and remained positive until the development of diabetes in 1988. To date, serum from 5 of 20 cytoplasmic islet cell antibody-positive relatives reacted with the expressed protein, while none of 14 control sera reacted. On Western blotting, the initial patient's serum used for the screening reacts with a 52-kDa antigen corresponding to the mol wt of the membrane form of carboxypeptidase-N. The current study has identified carboxypeptidase-H as an autoantigen recognized by serum of pretype I diabetes, and the methodology used should aid in identification of additional autoantigens associated with type I diabetes.

This article has been cited by other articles:

				J. M. Wenzlau, K. Juhl, L. Yu, O. Moua, S. A. Sarkar, P. Gottlieb, M. Rewers, G. S. Eisenbarth, J. Jensen, H. W. Davidson, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes PNAS, October 23, 2007; 104(43): 17040 - 17045. [Abstract] [Full Text] [PDF]

				A. Muntasell, M. Carrascal, L. Serradell, P. v. Veelen, F. Verreck, F. Koning, G. Raposo, J. Abian, and D. Jaraquemada HLA-DR4 Molecules in Neuroendocrine Epithelial Cells Associate to a Heterogeneous Repertoire of Cytoplasmic and Surface Self Peptides J. Immunol., November 1, 2002; 169(9): 5052 - 5060. [Abstract] [Full Text] [PDF]

				W. E. Winter, N. Harris, and D. Schatz Immunological Markers in the Diagnosis and Prediction of Autoimmune Type 1a Diabetes Clin. Diabetes, October 1, 2002; 20(4): 183 - 191. [Abstract] [Full Text] [PDF]

				Y. Ma, M. G. Thomas, M. Okamoto, D. P. Bogdanos, S. Nagl, N. Kerkar, A. R. Lopes, L. Muratori, M. Lenzi, F. B. Bianchi, et al. Key Residues of a Major Cytochrome P4502D6 Epitope Are Located on the Surface of the Molecule J. Immunol., July 1, 2002; 169(1): 277 - 285. [Abstract] [Full Text] [PDF]

				M. Pilon, X.-R. Peng, A. M. Spence, R. H.A. Plasterk, and H.-M. Dosch The Diabetes Autoantigen ICA69 and Its Caenorhabditis elegans Homologue, ric-19, Are Conserved Regulators of Neuroendocrine Secretion Mol. Biol. Cell, October 1, 2000; 11(10): 3277 - 3288. [Abstract] [Full Text]

				F. Dotta, M. Previti, M. Neerman-Arbez, S. Dionisi, D. Cucinotta, L. Lenti, U. Di Mario, and P. A. Halban The GM2-1 Ganglioside Islet Autoantigen in Insulin-Dependent Diabetes Mellitus Is Expressed in Secretory Granules and Is Not {beta}-Cell Specific Endocrinology, January 1, 1998; 139(1): 316 - 319. [Abstract] [Full Text] [PDF]

				M. A. Atkinson and N. K. Maclaren The Pathogenesis of Insulin-Dependent Diabetes Mellitus N. Engl. J. Med., November 24, 1994; 331(21): 1428 - 1436. [Full Text]